Cyclic compounds and compositions as protein kinase inhibitors
US7151096B2 · kind B2 · utility
10Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Dec 19, 2006 |
| Priority date | — |
| Expiry date | May 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides a novel class of cyclic compounds, pharmaceutical compositions comprising such cyclic compounds and methods of using such compounds to treat or prevent diseases and disorders associated with cyclin-dependent kinases (CDKs) activity, particularly diseases associated with the activity of CDK2 and CDK5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.